271 results
8-K
EX-99.1
PRPO
Precipio Inc
20 Apr 05
Other Events
12:00am
of the Private Securities
Litigation Reform Act of 1995, which involve known and unknown risks,
uncertainties and other factors that may cause our … contained in the Private Securities Litigation
Reform Act of 1995 with respect to all statements contained in this press
release. All information
8-K
EX-99.1
PRPO
Precipio Inc
28 Apr 04
Other events
12:00am
statements" of Transgenomic within the meaning of the Private Securities
Litigation Reform Act of 1995, which involve known and unknown risks … the
protection of the safe harbor for forward-looking statements contained in the
Private Securities Litigation Reform Act of 1995 with respect to all
statements
8-K
EX-99.1
PRPO
Precipio Inc
3 Feb 12
Transgenomic Announces $22.0 Million Private Placement Financing
12:00am
“forward-looking statements” of Transgenomic within the meaning of the Private Securities Litigation Reform Act of 1995, which involve known and unknown … , Transgenomic claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995
8-K
EX-99.1
PRPO
Precipio Inc
5 Apr 06
Departure of Directors or Principal Officers
12:00am
of the Private Securities Litigation Reform
Act of 1995, which involve known and unknown risks, uncertainties and other
factors that may cause our actual … -looking statements contained in the Private Securities Litigation Reform
Act of 1995 with respect to all statements contained in this press release
8-K
EX-99.1
PRPO
Precipio Inc
6 Jan 12
Transgenomic Announces $3 Million Convertible Note Financing
12:00am
Certain statements in this press release constitute “forward-looking statements” of Transgenomic within the meaning of the Private Securities Litigation … in the Private Securities Litigation Reform Act of 1995 with respect to all statements contained in this press release. All information in this press
8-K
EX-99.1
cbg81ey
22 Feb 06
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
EX-99.1
yiwyvuq5kb dn1tf
18 Mar 05
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
3rl6w9ard
6 Mar 14
Transgenomic Announces $7 Million Convertible Preferred Stock Financing
12:00am
8-K
EX-99.1
5ov0yemc8eknuhgdz
26 May 09
Transgenomic, Inc. Announces Appointment of New Board Members
12:00am
8-K
EX-99.1
tysyal5qkl rqrwho
19 Mar 14
Dr. Michael A. Luther Joins Transgenomic’s Board of Directors
12:00am
8-K
EX-99.1
61y19
26 May 09
Transgenomic, Inc. Announces Appointment of New Board Members
12:00am
8-K
EX-99.1
i1fs arqxry
1 Feb 06
Other Events
12:00am
8-K
EX-99.2
hrhx49e7ix5a ln
14 Jan 15
Regulation FD Disclosure
12:00am
8-K
EX-99.1
jj8bqd
4 Jan 11
Transgenomic Announces Closing of the Acquisition of Clinical Data’s Diagnostic Business and the Closing of a $6 Million Financing
12:00am
8-K
EX-99.1
vqxzahi
5 Feb 08
Departure of Directors or Principal Officers
12:00am
8-K
EX-99.1
jc1 l0d7u1gj5om0b
20 Feb 07
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
EX-99.1
ckk giktq1mkx
17 Aug 06
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
EX-99
8zc84ivg02
15 Jul 05
Other Events
12:00am
8-K
EX-99
ew50pnm8cv ya
20 Jun 05
Other Events
12:00am
8-K
EX-99.1
u3jxlx9k
12 Jul 06
Departure of Directors or Principal Officers
12:00am